|
Audience: This activity is intended for
healthcare professionals practicing in managed care environments.
This activity is supported by an
educational grant from Eli Lilly
PLEASE CLICK HERE TO VIEW PRESENTATION
PLEASE CLICK HERE FOR POST TEST AND
EVALUATION
Instructions for CME/CEU: View the presentation, answer the
post test, complete the evaluation form and submit to
keads@namcp.org. You will
have the option on the post test/evaluation page to submit your
forms electronically or by faxing them to Katie Eads at
804-747-5316.
Summary
Major
depressive disorder is a costly disease to patients, families, and
society. The treatment approach in depression has evolved to focus
on achieving remission. This is important for preventing relapse and
functional and structural changes to the brain from the effects of
inappropriately treated depression. Several areas of the brain,
including the hippocampus, are important in the pathophysiology,
consequences, and treatment of depression.
Objectives
-
Describe
the health implications for patients with depression
-
Discuss
behavior modifications that may help in treating depression
-
Evaluate
treatment options when behavior changes are not enough
|
Faculty: |
Roueen Rafeyan, MD, Medical
Director, Rush Behavioral Health, Rush University
Medical Center |
| |
|
|
Disclosure:
|
Dr. Rafeyan servers on the
speakers bureau for Abbott, AstraZeneca, Bristol
Myers-Squibb, Eli Lilly, Forest, Janssen and Wyeth. He
has received research grants from Sepracor. He has
served on advisory boards for Abbott, AstraZeneca,
Forest, GlaxoSmithKline and Pfizer. |
Accreditation & Designation
The National Association of Managed
Care Physicians (NAMCP) is accredited by the Accreditation Council
for Continuing Medical Education to sponsor continuing medical
education for physicians. NAMCP designates this activity for a
maximum of 1 AMA PRA Category I creditsTM. Each physician should
claim credit commensurate with the extent of their participation in
the activity.
The American Association of Managed Care Nurses (AAMCN) has been
approved as a provider of continuing education by the Virginia
Nurses Association (VNA) VNA is accredited as an approver of
continuing education in nursing by the American Nurses Credentialing
Center’s Commission on Accreditation. Nurses who complete this
activity will be awarded 1.0 contact hours.
This activity has been approved by the American Board of Managed
Care Nursing for 1.0 contact hours toward CMCN recertification
requirements.
This activity is
supported by an educational grant from Eli Lilly
|